Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases
Marinde J. G. Bond(Utrecht University), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Theodora C. Linders(The Netherlands Cancer Institute), Remond J.A. Fijneman(Amsterdam UMC Location VUmc), Karen Bolhuis(The Netherlands Cancer Institute), Anne M. May(Utrecht University), Clinton Mijnals(OLVG), Daan van den Broek(The Netherlands Cancer Institute), Cornelis J.A. Punt(University of Amsterdam)
Cited by 1
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2010|1k
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694
From tumour heterogeneity to advances in precision treatment of colorectal cancer
|Nature Reviews Clinical Oncology|2016|692